As of Apr 20
| +0.09 / +2.87%|
The 5 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +85.76% increase from the last price of 3.23.
The current consensus among 8 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.